Encompass Health Corporation
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$45.9M
8 notices · 386,961 sh
Oct 2025 to Oct 2026
Reported ·
$21.4M
12 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 12 reported sales carry the 10b5-1 box. Together they are 0.20% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-08-31John Patrick Darby, EVP, Gen Counsel & Secretary$588,256
2026-08-10Mark Tarr, President & CEO$21.7M
2026-08-10John Patrick Darby, EVP, Gen Counsel & Secretary$1,121,701
2026-08-10Douglas Coltharp, EVP & Chief Financial Officer$2,365,701
2026-05-15Douglas Edward Coltharp, EVP & Chief Financial Officer$2,958,629
Form 4, 2026-05-18: sold 27,694 at $106.83 Form 4 ↗
2026-05-11Patrick Tuer, EVP, Chief Operating Officer$71,312
Form 4, 2026-05-12: sold 682 at $104.56 Form 4 ↗
2026-02-11Mark Tarr, President & CEO$16.7M
Form 4, 2026-02-12: sold 150,000 at $111.64 Form 4 ↗